URTICARIA

This phase 2 trial tested an oral drug called povorcitinib in 136 adults with chronic spontaneous urticaria (hives and itching lasting months) that standard antihistamines couldn't control. Participants took either povorcitinib or a placebo for 12 weeks to see if the drug reduced…

This study tested whether an artificial intelligence (AI) device could help doctors more accurately identify 13 different skin conditions, from rashes to skin cancer. Sixteen doctors (10 general practitioners and 6 dermatologists) reviewed 29 medical images, first diagnosing with…

This study tested whether an artificial intelligence (AI) tool could help primary care doctors more accurately diagnose skin conditions like melanoma, psoriasis, and eczema. Nine doctors reviewed 30 skin images, first diagnosing on their own and then with the AI's suggestions. Th…

This study tested a daily tablet called NatureU Histra Disslove in 19 adults with chronic hives. Participants took one tablet before a main meal for 28 days. The study measured how well the tablet controlled hives, reduced symptoms, and improved quality of life. Results showed ch…

This study tested a single dose of a nasal spray called ARS-1 (intranasal epinephrine) in 21 adults who get frequent hives and itching. The goal was to see if the spray works faster and better than a placebo at reducing itch and hive scores during flare-ups. Participants were mon…

This study looked at whether a single antihistamine works as well as antihistamine plus steroids for treating sudden hives in the emergency department. 137 adults with acute hives (with or without mild swelling) took part. The goal was to see if adding steroids is necessary for s…